Board. Amplexa currently offers the following targeted Next Generation Sequencing (tNGS) panels in endocrinology.
See all Amplexa’s endocrinology tests (downloaded here). Some diseases and conditions are described in more detail below.
Hyper-Parathyroidism (5-7 genes)
Hypo-Parathyroidism (4-8 genes)
Pseudohypo-Parathyroidism (1 gene; 2 phenotypes)
Osteogenesis Imperfecta (2 genes).
This test is DS/EN ISO 15189:2013 accredited.
We can extract single genes from our panels or create virtual panels customized to your wishes by blinding ourselves to the genes you want to leave out. This way, we customize our analysis to your needs.
Contact us with your order – prices vary accordingly.